← Leaderboards
John Adams
University Of South Florida
$29,453,928
Attributed
$31,611,913
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,611,913 · 12
By mechanism
R01$24,724,367 · 6
U01$4,835,728 · 1
R21$1,507,878 · 4
R56$543,940 · 1
Top collaborators
- Michael T Ferdig5 shared
- Qin Cheng2 shared
- Jessica Lin2 shared
Most similar at University Of South Florida
Same institution · by research overlap
- Dipak Kumar Raj$2,773,174
- Liwang Cui$22,085,389
- Jun Miao$823,500
- Terrence M Quinn$1,284,462
- Timothy M Conway$1,961,930
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
MalariaParasitesPlasmodium FalciparumBloodInfectionGenesGlobal HealthPhenotypeBasePlasmodium VivaxVaccinesBinding ProteinsVaccine DevelopmentEpitopesLibrariesAntimalarialsResponseDesignIn VitroAfricaPlasmodiumMutantProgramsImmunity
Grant awards (60)
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine$882,985
U01 · FY2025 · AI · contact PI
Phenotype-based Screens to Identify Genetic Factors Associated with Gametocyte Development in Plasmodium falciparum$700,288
R01 · FY2025 · AI · contact PI
Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance$639,561
R01 · FY2025 · AI · contact PI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine$965,047
U01 · FY2024 · AI · contact PI
Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance$652,918
R01 · FY2024 · AI · contact PI
Discovering the Essential Genome of Plasmodium Falciparum$543,940
R56 · FY2024 · AI · contact PI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine$975,499
U01 · FY2023 · AI · contact PI
Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance$678,606
R01 · FY2023 · AI · contact PI
Immunological characterization of the P. vivax DBP$577,726
R01 · FY2023 · AI · contact PI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine$975,965
U01 · FY2022 · AI · contact PI
Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance$694,778
R01 · FY2022 · AI · contact PI
Immunological characterization of the P. vivax DBP$584,500
R01 · FY2022 · AI · contact PI
Plasmodium ovale hypnozoite development and relapse: a coordinated in vivo in vitro study$176,844
R21 · FY2022 · AI
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine$1,036,232
U01 · FY2021 · AI · contact PI
Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance$736,437
R01 · FY2021 · AI · contact PI
Discovering the essential genome of Plasmodium falciparum$643,737
R01 · FY2021 · AI · contact PI
Immunological characterization of the P. vivax DBP$611,722
R01 · FY2021 · AI · contact PI
Plasmodium ovale hypnozoite development and relapse: a coordinated in vivo in vitro study$240,758
R21 · FY2021 · AI
Evaluation of ivermectin as an antimalarial therapy against P. falciparum liver stage$157,252
R21 · FY2021 · AI · contact PI
Discovering the essential genome of Plasmodium falciparum$656,563
R01 · FY2020 · AI · contact PI
Immunological characterization of the P. vivax DBP$641,106
R01 · FY2020 · AI · contact PI
Evaluation of ivermectin as an antimalarial therapy against P. falciparum liver stage$204,036
R21 · FY2020 · AI · contact PI
Discovering the essential genome of Plasmodium falciparum$777,166
R01 · FY2019 · AI · contact PI
Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance$688,697
R01 · FY2019 · AI · contact PI
Immunological characterization of the P. vivax DBP$615,144
R01 · FY2019 · AI · contact PI
Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance$703,889
R01 · FY2018 · AI · contact PI
Discovering the essential genome of Plasmodium falciparum$697,594
R01 · FY2018 · AI · contact PI
Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance$715,282
R01 · FY2017 · AI · contact PI
Immunological characterization of the P. vivax DBP$647,388
R01 · FY2017 · AI · contact PI
Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance$715,282
R01 · FY2016 · AI · contact PI
Immunological characterization of the P. vivax DBP$653,630
R01 · FY2016 · AI · contact PI
Immunological characterization of the P. vivax DBP$812,322
R01 · FY2015 · AI · contact PI
Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance$718,381
R01 · FY2015 · AI · contact PI
A large-scale transposon mutagenesis screen of Plasmodium falciparum$367,500
R01 · FY2015 · AI · contact PI
Immunological characterization of the P. vivax DBP$679,540
R01 · FY2014 · AI · contact PI
A large-scale transposon mutagenesis screen of Plasmodium falciparum$367,500
R01 · FY2014 · AI · contact PI
Immunological characterization of the P. vivax DBP$673,463
R01 · FY2013 · AI · contact PI
A large-scale transposon mutagenesis screen of Plasmodium falciparum$374,481
R01 · FY2013 · AI · contact PI
Genetic screen for P. vivax CQR$180,146
R21 · FY2013 · AI · contact PI
A large-scale transposon mutagenesis screen of Plasmodium falciparum$330,750
R01 · FY2012 · AI · contact PI
Genetic screen for P. vivax CQR$176,692
R21 · FY2012 · AI · contact PI
A large-scale transposon mutagenesis screen of Plasmodium falciparum$348,888
R01 · FY2011 · AI · contact PI
Immunological characterization of the P. vivax DBP$697,044
R01 · FY2010 · AI · contact PI
Immunological characterization of the P. vivax DBP$679,373
R01 · FY2009 · AI · contact PI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$307,653
R01 · FY2009 · AI · contact PI
Immunological characterization of the P. vivax DBP$578,646
R01 · FY2008 · AI · contact PI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$307,305
R01 · FY2008 · AI · contact PI
Immunological characterization of the P. vivax DBP$585,452
R01 · FY2007 · AI · contact PI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$306,965
R01 · FY2007 · AI · contact PI
Developing a Transposon-based Toolkit for Genetic Analysis of Malaria Parasites$105,246
R21 · FY2007 · AI · contact PI
Developing a Transposon-based Toolkit for Genetic Analysis of Malaria Parasites$40,404
R21 · FY2007 · AI · contact PI
Immunological characterization of the P. vivax DBP$559,609
R01 · FY2006 · AI · contact PI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$329,570
R01 · FY2006 · AI · contact PI
Developing a Transposon-based Toolkit for Genetic Analysis of Malaria Parasites$226,500
R21 · FY2006 · AI · contact PI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$356,250
R01 · FY2005 · AI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$259,875
R01 · FY2004 · AI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$259,875
R01 · FY2003 · AI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$246,881
R01 · FY2002 · AI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$260,750
R01 · FY2001 · AI
MOLECULAR ANALYSIS OF APICAL ORGANELLES OF PLASMODIUM$284,280
R01 · FY2000 · AI